José María
Raya Sánchez
Profesor Asociado Asistencial
Hospital Universitario de Salamanca
Salamanca, EspañaHospital Universitario de Salamanca -ko ikertzaileekin lankidetzan egindako argitalpenak (9)
2024
2023
-
CNL and aCML should be considered as a single entity based on molecular profiles and outcomes
Blood Advances, Vol. 7, Núm. 9, pp. 1672-1681
-
Machine Learning Improves Risk Stratification in Myelofibrosis: An Analysis of the Spanish Registry of Myelofibrosis
HemaSphere, Vol. 7, Núm. 1, pp. E818
2022
-
Predictors of thrombosis and bleeding in 1613 myelofibrosis patients from the Spanish Registry of Myelofibrosis
British Journal of Haematology, Vol. 199, Núm. 4, pp. 529-538
2017
-
Bone marrow biopsy superiority over PET/CT in predicting progression-free survival in a homogeneously-treated cohort of diffuse large B-cell lymphoma
Cancer Medicine, Vol. 6, Núm. 11, pp. 2507-2514
2016
2015
-
Management of side effects of BCR/ABL-negative chronic myeloproliferative neoplasm therapies. Focus on anagrelide
Expert Review of Hematology, Vol. 8, Núm. 6, pp. 819-835
2012
-
Prognostic value of trisomy 8 as a single anomaly and the influence of additional cytogenetic aberrations in primary myelodysplastic syndromes
British Journal of Haematology, Vol. 159, Núm. 3, pp. 311-321